Aptevo Therapeutics Inc. Proceeds from Issuance of Other Long-term Debt
Aptevo Therapeutics Inc. (APVO) reported Proceeds from Issuance of Other Long-term Debt of $24.73 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt · last filed 2022-03-24
- Aptevo Therapeutics Inc. proceeds from issuance of other long-term debt for the quarter ending 2020-12-31 was $1.00K.
- Aptevo Therapeutics Inc. proceeds from issuance of other long-term debt for fiscal 2020 was $24.73M.
| Period end | Proceeds from Issuance of Other Long-term Debt 3 month | Proceeds from Issuance of Other Long-term Debt 9 month | Proceeds from Issuance of Other Long-term Debt 12 month |
|---|---|---|---|
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $24.73M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $24.73M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |